Piperacillin-induced immune hemolysis: new cases and a concise review of the literature-Reference-Cited by-同舟云学术

Piperacillin-induced immune hemolysis: new cases and a concise review of the literature

Published:2009-12-29 Issue:5 Volume:50 Page:1135-1138
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:

Author:

Mayer Beate,Yürek Salih,Salama Abdulgabar

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2009.02544.x/fullpdf

Reference20 articles.

1. Piperacillin-induced anemia and leukopenia;Bressler;South Med J,1986

2. Piperacillin-dependent antibody with relative specifity reacting with drug treated red cells and untreated red cells in the presence of drug;Johnson;Transfusion,1994

3. Hemolytic anaemia following treatment with piperacillin in a patient with cystic fibrosis;Thickett;J Antimicrob Chemother,1999

4. Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the “immune complex” method;Arndt;Vox Sang,2002

5. One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia-a new paradigm;Johnson;Transfusion,2007

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphocyte transformation tests predict delayed-type allergy to piperacillin/tazobactam in patients with cystic fibrosis;Journal of Cystic Fibrosis;2023-12

2. In macrohematuria, medication history also needs to be considered;Die Innere Medizin;2023-07-26

3. Piperacillin-tazobactam induced immune hemolytic anemia led to increased renal impairment and eventual death from multiple organ failure in a patient with hypertensive nephropathy: case report and literature review;BMC Nephrology;2023-06-14

4. Medikamentös induzierte Immunhämolysen;Transfusionsmedizin;2023-05

5. Drug-induced immune hemolytic anemia investigation: Comparison between tube test and microcolumn agglutination (gel test) for the detection of drug-dependent antibodies in the presence of soluble drug;Transfusion Clinique et Biologique;2020-08